(Q72425520)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

title

Comparison of three methods of central-nervous-system prophylaxis in childhood acute lymphoblastic leukaemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

author name string

D. M. Green

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

A. I. Freeman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

H. N. Sather

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

S. E. Sallan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

M. E. Nesbit

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

J. R. Cassady

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

L. F. Sinks

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

D. Hammond

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

E. Frei

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6104182

5 August 2023

language of work or name

English

0 references

publication date

1 June 1980

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

28 June 1980

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6104182

full work available at URL

5 August 2023

https://api.elsevier.com/content/article/PII:S0140673680926641?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

https://api.elsevier.com/content/article/PII:S0140673680926641?httpAccept=text/plain

5 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

5 August 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

issue

8183

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

page(s)

1398-1402

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

CENTRAL NERVOUS SYSTEM INVOLVEMENT IN CHILDREN WITH ACUTE LEUKEMIA; A STUDY OF 921 PATIENTS

26 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

The increasing incidence of central nervous system leukemia in children. (Children's Cancer Study Group A).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

1 reference

7 January 2021

Long-term control of central nervous system leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Central nervous system lesions in childhood leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Acute and chronic effects of methotrexate on hepatic, pulmonary, and skeletal systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

The histopathologic basis for functional decrements in late radiation injury in diverse organs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Childhood acute lymphocytic leukemia. Study VIII

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Abnormal CT Scans of the Brain in Asymptomatic Children with Acute Lymphocytic Leukemia after Prophylactic Treatment of the Central Nervous System with Radiation and Intrathecal Chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

CAT brain scans after central nervous system prophylaxis for acute lymphoblastic leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Enlargement of subarachnoid spaces and lateral ventricles in pediatric patients undergoing chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Computed tomography brain scans in children with acute lymphocytic leukemia receiving methotrexate alone as central nervous system prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Intellectual abilities among survivors of childhood leukaemia as a function of CNS irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Effects of central-nervous-system irradiation on neuropsychologic functioning of children with acute lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Distribution of Ia-like molecules on the surface of normal and leukemic human cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Immunological Classification of Acute Lymphoblastic Leukaemias: Evaluation of its Clinical Significance in a Hundred Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Surface Markers and Prognostic Factors in Acute Lymphoblastic Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Prevention of central nervous system leukemia by irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

The role of irradiation in central nervous system treatment and prophylaxis for acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Superiority of conventional intrathecal methotrexate therapy with maintenance over intensive intrathecal methotrexate therapy, unmaintained, or radiotherapy (2000-2500 rads tumor dose) in treatment for meningeal leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2880%2992664-1

7 January 2021

Effects of chemotherapy on the central nervous system. A study of parenteral methotrexate in long-term survivors of leukemia and lymphoma in childhood

11

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

High-dose methotrexate in acute lymphocytic leukemia

5 August 2023

22

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results

5 August 2023

24

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

Clinical pharmacology of intrathecal methotrexate. II. An improved dosage regimen derived from age-related pharmacokinetics

5 August 2023

33

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(80)92664-1

5 August 2023

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:6104182%20AND%20SRC:MED&resulttype=core&format=json

26 October 2019

1 reference